Forty Seven, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | |
|---|---|---|---|
| Revenue | $15.7M | — | — |
| Operating income | −$88.5M | −$72.1M | −$10.9M |
| Net income | −$87.6M | −$70.4M | −$10.9M |
| Total assets | $343.6M | $149.4M | $95.5M |
| Total liabilities | $25.7M | $16.2M | $12.0M |
| Equity | $317.9M | $133.2M | $83.5M |
| EPS (diluted) | — | — | — |
| Shares out. | 31.3M | 31.1M | 6.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −564.7%
- Net margin
- −558.9%
- Return on equity
- −27.6%
- Return on assets
- −25.5%
- Return on capital (ROCE)
- −27.6%
- Liabilities / assets
- 7.5%
- Debt / equity
- 0.08×
- Book value / share
- $10.17
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- 15.13safe
- Accruals / assets
- −2.8%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 3 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Bird Jeffrey WDirector | Apr 7, 2020 | D | 562,500 | — |
| Weissman IrvingDirector | Mar 26, 2020 | Gift | 279,000 | $0.00 |
| Majeti RavindraDirector | Mar 30, 2020 | Gift | 1,000 | $0.00 |
| Gibbs Craig SOfficer — Chief Business Officer | Apr 1, 2020 | Gift | 9,124 | $0.00 |
| Takimoto Chris HOfficer — Chief Medical Officer | Apr 7, 2020 | D | 3,906 | — |
| Rhoads Ann DOfficer — Chief Financial Officer | Apr 7, 2020 | D | 37,414 | — |
| Mccamish Mark AnthonyOfficer — President and CEO | Apr 7, 2020 | D | 4,595 | — |
| Takimoto Chris HOfficer — Chief Medical Officer | Apr 1, 2020 | Option exercise | 49,627 | $2.02 |
| Rhoads Ann DOfficer — Chief Financial Officer | Apr 1, 2020 | Option exercise | 20,950 | $8.76 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 7, 2020
- Entered a material agreement · Other material eventMar 2, 2020
- Entered a material agreementJan 10, 2020
- Results of operationsJan 10, 2020
- Terminated a material agreement · Other material eventDec 12, 2019
- Results of operationsNov 12, 2019
- Results of operationsAug 13, 2019
- Other material eventJul 18, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BApr 17, 2020
- SC 13G/ASEC SCHEDULE 13GApr 9, 2020
- EFFECTApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 4FORM 4 SUBMISSIONApr 7, 2020
- 25-NSEApr 7, 2020
- POS462BApr 7, 2020